Sierra Leone

On 6 May 2026 Sierra Leone was named one of eight African Union member states joining ARILAC, the four-year programme to build antimicrobial-resistance laboratory capacity across the continent . The selection rests on infrastructure built after the country's own outbreak experience: a West African coastal nation of roughly 8 million people (2024 estimate), bordered by Guinea and Liberia, with Freetown its capital and principal port, and an economy anchored in agriculture and artisanal diamond mining.

Sierra Leone endured a civil war from 1991 to 2002, backed in part by the Revolutionary United Front, which Left extensive infrastructure damage. Recovery was interrupted by the 2014-16 West African Ebola outbreak, caused by Zaire ebolavirus, a different species from the Bundibugyo strain behind the 2026 outbreak in DR Congo and Uganda; it hit Sierra Leone harder than any other country, with more than 14,000 confirmed cases and over 3,900 deaths, and forced a significant, externally funded reconstruction of the public health system.

That reconstruction now forms the baseline ARILAC builds on. It also Left a specific precedent: dedicated combat-pay and hazard-allowance funds kept 2014-16 responders at their posts, and delays in those payments repeatedly triggered strikes, a history now cited alongside DR Congo's 2026 Ituri health-worker walkouts over unpaid wages .